Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116,466 | 131,524 | 117,626 | 105,722 | 154,585 |
| Receivables | 398,547 | 383,748 | 364,050 | 359,734 | 345,539 |
| Inventories | 104,690 | 98,482 | 95,833 | 99,374 | 98,116 |
| Other current assets | 67,693 | 43,872 | 45,008 | 52,921 | 66,609 |
| TOTAL | $738,067 | $700,121 | $656,832 | $654,578 | $701,547 |
| Non-Current Assets | |||||
| PPE Net | 758,724 | 746,951 | 755,827 | 767,177 | 783,678 |
| Intangibles | 845,899 | 826,358 | 861,808 | 841,277 | 837,220 |
| Other Non-Current Assets | 430,974 | 423,645 | 437,333 | 427,158 | 440,542 |
| TOTAL | $2,035,597 | $1,996,954 | $2,054,968 | $2,035,612 | $2,061,440 |
| Total Assets | $2,773,664 | $2,697,075 | $2,711,800 | $2,690,190 | $2,762,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 27,225 | 27,308 | 27,313 | 25,970 | 33,939 |
| Accounts payable and accrued liabilities | 64,652 | 60,987 | 68,485 | 65,809 | 66,198 |
| Accrued Expenses | 183,860 | 147,402 | 177,941 | 174,082 | 168,680 |
| Other current liabilities | 27,362 | 18,460 | 26,500 | 25,131 | 23,871 |
| TOTAL | $424,071 | $383,374 | $429,593 | $412,047 | $413,393 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,116,278 | 1,170,063 | 1,207,696 | 1,233,189 | 1,331,053 |
| Deferred Revenues | 119,336 | 127,591 | 127,731 | 119,298 | 118,837 |
| Other Non-Current Liabilities | 183,315 | 180,480 | 179,122 | 117,726 | 128,787 |
| TOTAL | $1,383,199 | $1,434,654 | $1,443,082 | $1,405,281 | $1,513,433 |
| Total Liabilities | $1,807,270 | $1,818,028 | $1,872,675 | $1,817,328 | $1,926,826 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,594 | 47,639 | 47,373 | 47,329 | 47,293 |
| Common Shares | 873 | 871 | 863 | 863 | 862 |
| Retained earnings | 266,033 | 212,081 | 165,303 | 120,623 | 82,888 |
| Other shareholders' equity | -205,254 | -239,601 | -251,412 | -160,817 | -145,315 |
| TOTAL | $966,394 | $879,047 | $839,125 | $872,862 | $836,161 |
| Total Liabilities And Equity | $2,773,664 | $2,697,075 | $2,711,800 | $2,690,190 | $2,762,987 |